ABIOCLAV

Active ingredients

The drug ABIOCLAV contains a combination of these active pharmaceutical ingredients (APIs):

UNII 804826J2HU - AMOXICILLIN

Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death.

Read about Amoxicillin
UNII 23521W1S24 - CLAVULANIC ACID

Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin.

Read about Clavulanic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
J01CR02
Amoxicillin and enzyme inhibitor
J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CR Combinations of penicillins, incl. beta-lactamase inhibitors
Discover more medicines within J01CR02

Authorization and marketing

This brand name is authorized in the following countries: Italy

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
IT
Agenzia Italiana del Farmaco
Identifier(s): 037350016, 037350028